OHSU Knight Cancer Institute — Biomedical Watch V2

Traitements2programmes

Essais1liés

Publications3liées

SourceDBlocale

Traitements

2

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
Fluorothymidine F-18This pilot early phase I trial studies how well fluorothymidine F-18 positron emission tomography (PET) works in imaging patients with intermediate or high grade soft tissue sarcoma. Fluorothymidine F-18 PET may provide useful information about the tumor's response to treatment and may give the doctors early results that would better help to plan the post-surgical therapy.	Cancer	Phase 1	À vérifier		À vérifier
Fluorothymidine F-18This pilot early phase I trial studies how well fluorothymidine F-18 positron emission tomography (PET) works in imaging patients with intermediate or high grade soft tissue sarcoma. Fluorothymidine F-18 PET may provide useful information about the tumor's response to treatment and may give the doctors early results that would better help to plan the post-surgical therapy.	Cancer	Phase 1	À vérifier		À vérifier

Essais cliniques

1

Molécule	Indication / population	Phase	NCT	Titre	Statut
Fluorothymidine F-18	Cancer	Phase 1	NCT03613259	Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue Sarcoma	WITHDRAWN

Publications

3

Molécule	Indication / population	Titre	Journal	Date
Fluorothymidine F-18		Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer.	Annals of nuclear medicine
Fluorothymidine F-18		Quantification of uptake in pelvis F-18 FLT PET-CT images using a 3D localization and segmentation CNN.	Medical physics
Fluorothymidine F-18		Assessing Bone Marrow Activity with []FLT PET in Patients with Essential Thrombocythemia and Prefibrotic Myelofibrosis: A Proof of Concept.	Technology in cancer research & treatment